What Really Happens When You Smoke Cannabis: Combustion Explained

Decarboxylation: Unlocking Potential

Raw cannabis flowers contain THCA (Tetrahydrocannabinolic acid). THCA is effectively dormant because it features a bulky carboxyl chain that prevents it from binding to your cannabinoid receptors.

Heat activates this compound through decarboxylation. As the "cherry" of a joint reaches temperatures between 600°C and 900°C (1,112°F to 1,652°F), it sheds that carboxyl group as CO2. This transformation happens at the burn site, turning THCA into Delta-9-THC, which is then carried into your respiratory system via smoke.

Pulmonary Absorption: Bypassing the Liver

Inhalation serves as a method for introducing cannabinoids to the bloodstream. By drawing smoke into the alveoli—the microscopic air sacs in the lungs—you utilize a large surface area (roughly 70 to 100 square meters) for gas exchange.

Because the cannabinoids enter systemic circulation through the alveolar-capillary membrane, they bypass "first-pass metabolism" in the liver. This explains the rapid onset of effects, usually felt within 2 to 10 minutes. Efficiency remains a balancing act:

• The Roll: A joint rolled too tightly creates resistance, leading to incomplete combustion and wasted material.
• The Burn: A loose roll encourages a rapid burn rate, which may destroy volatile compounds through excessive heat.
• Bioavailability: Under optimal conditions, roughly 10% to 35% of the available THC may reach the blood.

The ECS: Your Internal Regulatory Network

Your Endocannabinoid System is a lipid-based signaling network responsible for maintaining homeostasis—the body’s balance for sleep, hunger, pain, and immune response. When you inhale cannabis, you provide an exogenous supplement that mimics the body’s natural signaling molecules, like Anandamide.

The Receptor Split: CB1 vs. CB2

Cannabinoids act as keys, and ECS receptors are the locks.

• CB1 Receptors: Concentrated in the Central Nervous System (the hippocampus, cortex, and basal ganglia), these are where THC acts as a partial agonist. By binding here, it may alter the release of neurotransmitters like GABA and glutamate, resulting in the psychoactive experience: altered time perception, appetite stimulation, and euphoria.
• CB2 Receptors: These are located in the Peripheral Nervous System and immune cells. They do not provide a "high." Instead, they modulate inflammation and regulate immune responses. CBD and specific terpenes may interact with these sites to support the management of peripheral pain.

Retrograde Signaling: The Neural Brake

One aspect of cannabis is how it handles neural traffic. While most signals go from the sender (presynaptic) to the receiver (postsynaptic), cannabinoids work backward.

When a postsynaptic neuron fires too aggressively, it releases endocannabinoids that travel back across the synapse to the presynaptic neuron. This signals the sender to release fewer neurotransmitters. THC mimics this retrograde signaling, which suggests why cannabis may assist in dampening neuropathic pain and muscle spasticity by acting as a brake on overactive neurons.

The Entourage Effect and Thermodynamics

The experience is not limited to THC percentage. Aromatic hydrocarbons known as terpenes play a role in modulating the effect.

• Myrcene: May function as a gatekeeper, potentially increasing cell membrane permeability and helping THC cross the blood-brain barrier.
• Limonene: May influence adenosine and serotonin receptors, shifting the mood profile.
• Beta-Caryophyllene: Known to bind to CB2 receptors, acting as a dietary cannabinoid that targets inflammation.

The architecture of the joint matters. A well-constructed cylinder acts as a cooling path. As heat moves toward the filter, it pre-heats the unburnt flower, vaporizing the delicate terpenes before the flame reaches them. Grind consistency and packing density influence this process. A consistent, steady draw is the difference between a controlled extraction and simple pyrolysis, where compounds may be destroyed before they are absorbed.

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

1. Huestis MA. (2007). Human cannabinoid pharmacokinetics. Chem Biodivers. 4(8):1770-1804. PubMed

2. Grotenhermen F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 42(4):327-60. PubMed

3. Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed

4. Pertwee RG. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 153(2):199-215. PubMed